Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.785
-0.025 (-1.38%)
May 28, 2026, 12:54 PM EDT - Market open
Cardiff Oncology Employees
As of December 31, 2025, Cardiff Oncology had 31 total employees, including 30 full-time and 1 part-time employees. The number of employees decreased by 2 or -6.06% compared to the previous year.
Employees
31
Change (1Y)
-2
Growth (1Y)
-6.06%
Revenue / Employee
$16,935
Profits / Employee
-$1,444,742
Market Cap
122.04M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 31 | -2 | -6.06% | 30 | 1 |
| Dec 31, 2024 | 33 | 1 | 3.13% | 32 | 1 |
| Dec 31, 2023 | 32 | 6 | 23.08% | 31 | 1 |
| Dec 31, 2022 | 26 | 3 | 13.04% | 25 | 1 |
| Dec 31, 2021 | 23 | 11 | 91.67% | 22 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Alps Group | 93 |
| enGene Therapeutics | 82 |
| Alpha Cognition | 71 |
| Connect Biopharma Holdings | 64 |
| Genelux | 26 |
| Black Diamond Therapeutics | 21 |
| Spruce Biosciences | 8 |
CRDF News
- 6 days ago - Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC - GlobeNewsWire
- 13 days ago - Cardiff Oncology reports Q1 EPS (18c), consensus (12c) - TheFly
- 13 days ago - Cardiff Oncology sees cash, equivalents funding operations into 1Q27 - TheFly
- 13 days ago - Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update - GlobeNewsWire
- 14 days ago - Cardiff Oncology Quarterly report: Q1 2026 - Filings
- 14 days ago - Cardiff Oncology Earnings release: Q1 2026 - Filings
- 4 weeks ago - Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib's Promising Single-Agent Activity - GlobeNewsWire